Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | PKM | P14618 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA3 | P07451 | 1/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | CA6 | P23280 | 1/20 | 0.59 |
| ▸ | CA5A | P35218 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.59 |
| ▸ | TPMT | P51580 | 1/20 | 0.52 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL975675 | 0.83 | PTGS2 (1.00) | PTGS2LMNAPKMCA12CA1 | |
| SCHEMBL2338863 | 0.83 | LMNA (0.84) | PTGS2LMNAPKMCA12CA1 | |
| SCHEMBL30615314 | 0.83 | PTGS2 (1.00) | PTGS2LMNAPKMCA12CA1 | |
| SCHEMBL1465618 | 0.82 | KDM4E (0.77) | PTGS2LMNAPKMCA12CA1 | |
| SCHEMBL30594704 | 0.82 | KDM4E (0.77) | PTGS2LMNAPKMCA12CA1 | |
| SCHEMBL16358844 | 0.82 | PTGS2 (0.69) | PTGS2LMNAPKMCA12CA1 | |
| SCHEMBL13065514 | 0.82 | PTGS2 (0.69) | PTGS2LMNAPKMCA12CA1 | |
| Syringic Acid SCHEMBL6072775 | 0.80 | PTGS2 (0.92) | PTGS2LMNAPKMCA12CA1 | |
| SCHEMBL407763 | 0.79 | KDM4E (0.62) | LMNACA12CA1CA2CA3 | |
| SCHEMBL4735163 | 0.79 | PTGS2 (0.65) | PTGS2LMNAPKMCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1765761-B1 | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | LAILA NUTRACEUTICALS (IN) | 2013-04-03 | — | — | EP | claimed |
| US-20120035176-A1 | ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | LAILA NUTRACEUTICALS | 2012-02-09 | — | — | US | claimed |
| US-20090318551-A1 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | GOKARAJU GANGA RAJU | 2009-12-24 | — | — | US | claimed |
| US-7625947-B2 | Analogs of 3-O-acetyl-11-keto-β-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2009-12-01 | — | — | US | claimed |
| US-20060089409-A1 | Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2006-04-27 | — | — | US | claimed |
| US-8748598-B2 | Analogs of 3-O-acetyl-11-keto-beta-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2014-06-10 | — | — | US | disclosed |
| EP-1765761-B1 | NOVEL ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | LAILA NUTRACEUTICALS (IN) | 2013-04-03 | — | — | EP | disclosed |
| US-20120035176-A1 | ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | LAILA NUTRACEUTICALS | 2012-02-09 | — | — | US | disclosed |
| US-20090318551-A1 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | GOKARAJU GANGA RAJU | 2009-12-24 | — | — | US | disclosed |
| US-20090318551-A1 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | GOKARAJU GANGA RAJU | 2009-12-24 | — | — | US | disclosed |
| US-7625947-B2 | Analogs of 3-O-acetyl-11-keto-β-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2009-12-01 | — | — | US | disclosed |
| US-7625947-B2 | Analogs of 3-O-acetyl-11-keto-β-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2009-12-01 | — | — | US | disclosed |
| US-20060089409-A1 | Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2006-04-27 | — | — | US | disclosed |
| US-20060089409-A1 | Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid | LAILA NUTRACEUTICALS (IN) | 2006-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035176-A1 | ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | NFKBIA, ALOX12, ALOX15 | PTGS2 18/4885LMNA 1845/4885PKM 3430/4885 |
| US-20060089409-A1 | Novel analogs of 3-o-acetyl-11-keto-ß-boswellic acid | KAT2B, AKR1C3, ACACB | PTGS2 1866/4885LMNA 2084/4885PKM 2182/4885 |
| US-20090318551-A1 | USES OF ANALOGS OF 3-O-ACETYL-11-KETO-BETA-BOSWELLIC ACID | ACACB, KAT2B, AKR1C3 | PTGS2 1815/4885LMNA 1921/4885PKM 2073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.